✨ Education and Health Notices
1342 NEW ZEALAND GAZETTE, No. 57 30 APRIL 2009
Supplementary Integration Agreement
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Regional Education, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
Christchurch Adventist School.
The said supplementary integration agreement was executed on 22 April 2009.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the regional office of the Ministry of Education, 39 Princess Street, Christchurch.
Dated at Wellington this 22nd day of April 2009.
KATHY PHILLIPS, Group Manager, Regional Education, Ministry of Education.
Supplementary Integration Agreement
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Regional Education, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
St John’s Girls’ School, Invercargill.
The said supplementary integration agreement was executed on 20 April 2009.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the regional office of the Ministry of Education, 78 Doon Street, Invercargill.
Dated at Wellington this 20th day of April 2009.
KATHY PHILLIPS, Group Manager, Regional Education, Ministry of Education.
go3656 go3583
Health
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Aclasta
Active Ingredient: Zoledronic acid 0.05mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Glivec
Active Ingredient: Imatinib mesilate 119.5mg equivalent to 100mg imatinib
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Glivec
Active Ingredient: Imatinib mesilate 59.75mg equivalent to 50mg imatinib
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Glivec
Active Ingredient: Imatinib mesilate 119.5mg equivalent to 100mg imatinib
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Glivec
Active Ingredient: Imatinib mesilate 478mg equivalent to 400mg imatinib
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Next Page →
✨ LLM interpretation of page content
🎓 Supplementary Integration Agreement for Christchurch Adventist School
🎓 Education, Culture & Science22 April 2009
Supplementary Integration Agreement, Christchurch Adventist School, Education
- KATHY PHILLIPS, Group Manager, Regional Education, Ministry of Education
🎓 Supplementary Integration Agreement for St John’s Girls’ School
🎓 Education, Culture & Science20 April 2009
Supplementary Integration Agreement, St John’s Girls’ School, Invercargill, Education
- KATHY PHILLIPS, Group Manager, Regional Education, Ministry of Education
🏥 Consent to Distribution of Changed Medicines
🏥 Health & Social WelfareMedicines Act 1981, New Medicines, Distribution Consent, Novartis New Zealand Limited
- Minister of Health
NZ Gazette 2009, No 57